Changes

==Treatment==

==Treatment==

Animals with right-sided congestive heart failure require stablisation with diuretics, ACE inhibitors and cage rest before treatment for heartworm disease is implemented. Animals with severe respiratory signs also require stabilisation with oxygen supplementation, anti-inflammatory doses of corticosteroid and anti-thrombotic drugs. Adulticidal treatment involves the administration of

 

Decisions in the treatment of heartworm disease are dependent on the severity of infection. A scheme exists to classify patients in terms of disease severity². Class one patients have subclinical heartworm disease, and carry an excellent prognosis following treatment wiht adulticidal drugs. Class two animals show mild to moderate clinical signs and similar radiographic changes. These animals may respond positively to treatment. Dogs with class 3 disease have severe clinical signs, such as persistent coughing, dyspnoea, right-sided heart failure or haemoptysis, and these are reflected by severe radiographic signs. These cases have a high risk of pulmonary thromboembolism and so prognosis is guarded and the benefits of adulticidal treatment should be considered carefully.

 

Even low grade infections in cats may result in pulmonary thromboembolism with adulticidal treatment, and spontaneous remission is seen in some cats. Because of this, symptomatic treatment (cage rest, oxygen supplementation, fluid therapy, bronchodilators and dexamethasone) may be more appropriate in sick cats, and clinically well cats can merely be monitored regularly for remission. Adulticidal treatment should only be considered in cats that fail to respond to supportive treatments but are in a stable condition.

 

Adulticidal treatment involves the administration of

a new generation arsenical compound, melarsomine dihydrochloride

a new generation arsenical compound, melarsomine dihydrochloride

(Immiticide, Merial; this product is not

(Immiticide, Merial; this product is not

following subsequent adulticidal treatment.

following subsequent adulticidal treatment.

 

No drugs are specifically approved for microfilaricidal treatment of ''Dirofilaria immitis'', and successful elimination of adult worms should results in the demise of circulating microfilariae four to six weeks later². Single doses of ivermectin, milbemycin oxime, moxidection or selamectin are, however, effective at removing microfilariae from the circulation. The sudden death of large numbers of microfilariae may invoke an anaphylactic response, and oral prednisolone may be administered with microfilaricides to help prevent this.

No drugs are specifically approved for microfilaricidal treatment of ''Dirofilaria immitis'', and successful elimination of adult worms should results in the demise of circulating microfilariae four to six weeks later². Single doses of ivermectin, milbemycin oxime, moxidection or selamectin are, however, effective at removing microfilariae from the circulation. The sudden death of large numbers of microfilariae may invoke an anaphylactic response, and oral prednisolone may be administered with microfilaricides to help prevent this.

 

Heartworm prophylaxis should be implemented in all cats and dogs living in or visiting areas in which ''Dirofilaria immitis'' is endemic. In the UK, milbemycin oxime and selamectin are licensed for the prevention of heartworm disease and should be administered on a monthly basis as they are capable of killing migrating larvae up to week six post-infection. In the event of non-compliance or a missed dose, it may be necessary to test the animal for ''Dirofilaria immitis'' six months later if they are likely to have been exposed to infection during the time they were unprotected. Drugs that persist in the long term, such as injectable moxidectin, can help overcome this issue.

Heartworm prophylaxis should be implemented in all cats and dogs living in or visiting areas in which ''Dirofilaria immitis'' is endemic. In the UK, milbemycin oxime and selamectin are licensed for the prevention of heartworm disease and should be administered on a monthly basis as they are capable of killing migrating larvae up to week six post-infection. In the event of non-compliance or a missed dose, it may be necessary to test the animal for ''Dirofilaria immitis'' six months later if they are likely to have been exposed to infection during the time they were unprotected. Drugs that persist in the long term, such as injectable moxidectin, can help overcome this issue.